CD-20-0142R1_Supplementary_Table_S2.xlsx from BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, is Effective in KRAS-Driven Cancers Through Combined MEK Inhibition Marco H. Hofmann , Michael Gmachl , Juergen Ramharter , Fabio Savarese , Daniel Gerlach , Joseph R. Marszalek , Michael P. Sanderson , Dirk Kessler , Francesca Trapani , Heribert Arnhof , Klaus Rumpel , Dana-Adriana Botesteanu , Peter Ettmayer , Thomas Gerstberger , Christiane Kofink , Tobias Wunberg , Andreas Zoephel , Szu-Chin Fu , Jessica L. Teh , Jark Böttcher , Nikolai Pototschnig , Franziska Schachinger , Katharina Schipany , Simone Lieb , Christopher P. Vellano , Jonathan C. O'Connell , Rachel L. Mendes , Jurgen Moll , Mark Petronczki , Timothy P. Heffernan , Mark Pearson , Darryl B. McConnell , Norbert Kraut openalex（2023）
Key words
MEK Inhibition, Cancer Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
